BR112014004591A2 - light exposure analysis pharmaceutical product of a pharmaceutical product - Google Patents

light exposure analysis pharmaceutical product of a pharmaceutical product

Info

Publication number
BR112014004591A2
BR112014004591A2 BR112014004591A BR112014004591A BR112014004591A2 BR 112014004591 A2 BR112014004591 A2 BR 112014004591A2 BR 112014004591 A BR112014004591 A BR 112014004591A BR 112014004591 A BR112014004591 A BR 112014004591A BR 112014004591 A2 BR112014004591 A2 BR 112014004591A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical product
light exposure
exposure analysis
analysis
pharmaceutical
Prior art date
Application number
BR112014004591A
Other languages
Portuguese (pt)
Inventor
Shnek Deborah
Guo Jeremy
Sun Li
Spencer Paula
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of BR112014004591A2 publication Critical patent/BR112014004591A2/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D79/00—Kinds or details of packages, not otherwise provided for
    • B65D79/02—Arrangements or devices for indicating incorrect storage or transport
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01D—MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
    • G01D7/00—Indicating measured values
    • G01D7/005—Indication of measured value by colour change
BR112014004591A 2011-09-02 2012-08-31 light exposure analysis pharmaceutical product of a pharmaceutical product BR112014004591A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161530824P 2011-09-02 2011-09-02
PCT/US2012/053450 WO2013033600A1 (en) 2011-09-02 2012-08-31 Pharmaceutical product and method of analysing light exposure of a pharmaceutical product

Publications (1)

Publication Number Publication Date
BR112014004591A2 true BR112014004591A2 (en) 2017-03-28

Family

ID=46982918

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014004591A BR112014004591A2 (en) 2011-09-02 2012-08-31 light exposure analysis pharmaceutical product of a pharmaceutical product

Country Status (13)

Country Link
US (1) US20140315187A1 (en)
EP (1) EP2750989A1 (en)
JP (1) JP2014529473A (en)
KR (1) KR20140058669A (en)
CN (1) CN103917458A (en)
AU (1) AU2012301656A1 (en)
BR (1) BR112014004591A2 (en)
CA (1) CA2840637A1 (en)
CL (1) CL2014000104A1 (en)
EA (1) EA201490555A1 (en)
MX (1) MX2014002533A (en)
WO (1) WO2013033600A1 (en)
ZA (1) ZA201309704B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016202785A1 (en) 2015-06-17 2016-12-22 Novozymes A/S Container
IL250601B (en) * 2017-02-14 2018-05-31 Marpaz Tech Ltd Container for photosensitive material
CN113454438A (en) * 2019-02-22 2021-09-28 科慕埃弗西有限公司 Method for determining the light-sensitive properties of a material

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
EP0117390B1 (en) * 1983-02-25 1990-09-05 Lifelines Technology, Inc. Process for monitoring incremental environmental exposures of products that undergo progressive quality changes in response to environment stimuli
AU588819B2 (en) 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
AU643427B2 (en) 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
US5395760A (en) 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
ATE194384T1 (en) 1989-09-12 2000-07-15 Hoffmann La Roche TNF-BINDING PROTEINS
US6204363B1 (en) 1989-10-16 2001-03-20 Amgen Inc. Stem cell factor
US5149792A (en) 1989-12-19 1992-09-22 Amgen Inc. Platelet-derived growth factor B chain analogs
US5272064A (en) 1989-12-19 1993-12-21 Amgen Inc. DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof
WO1991018982A1 (en) 1990-06-05 1991-12-12 Immunex Corporation Type ii interleukin-1 receptors
US5350683A (en) 1990-06-05 1994-09-27 Immunex Corporation DNA encoding type II interleukin-1 receptors
US5962406A (en) 1991-10-25 1999-10-05 Immunex Corporation Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same
JPH06174600A (en) * 1992-09-16 1994-06-24 Caterpillar Inc Method and device for displaying change of state
NZ257942A (en) 1992-10-23 1996-04-26 Immunex Corp Preparing a mammalian protein by expression of a fusion protein containing a leucine zipper domain
US5554512A (en) 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
US5981713A (en) 1994-10-13 1999-11-09 Applied Research Systems Ars Holding N.V. Antibodies to intereleukin-1 antagonists
NZ311982A (en) 1995-06-29 1999-08-30 Immunex Corp Tnf related apoptosis inducing ligand (trail), a method for producing them and associated antibodies
US6613544B1 (en) 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
US6096728A (en) 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
US6271349B1 (en) 1996-12-23 2001-08-07 Immunex Corporation Receptor activator of NF-κB
US6235883B1 (en) 1997-05-05 2001-05-22 Abgenix, Inc. Human monoclonal antibodies to epidermal growth factor receptor
US6337072B1 (en) 1998-04-03 2002-01-08 Hyseq, Inc. Interleukin-1 receptor antagonist and recombinant production thereof
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
AU1920301A (en) 1999-11-17 2001-05-30 Immunex Corporation Receptor activator of nf-kappa b
AU2001259432B2 (en) 2000-05-03 2005-04-21 Amgen Inc. Modified peptides, comprising an FC domain, as therapeutic agents

Also Published As

Publication number Publication date
EA201490555A1 (en) 2014-07-30
JP2014529473A (en) 2014-11-13
CL2014000104A1 (en) 2014-07-25
EP2750989A1 (en) 2014-07-09
ZA201309704B (en) 2014-08-27
US20140315187A1 (en) 2014-10-23
WO2013033600A1 (en) 2013-03-07
KR20140058669A (en) 2014-05-14
AU2012301656A1 (en) 2014-01-16
CA2840637A1 (en) 2013-03-07
CN103917458A (en) 2014-07-09
MX2014002533A (en) 2014-08-26

Similar Documents

Publication Publication Date Title
BR112014021740A2 (en) devices for optically determining a characteristic of a substance
BR112014005273A2 (en) apparatus and apparatus for forming an optical beam from an extended light source
SMT201500209B (en) Pharmaceutical controlled release dosage forms
DK2694038T3 (en) PHARMACEUTICAL COMPOSITION
DK3181122T3 (en) DASATINIB PHARMACEUTICAL COMPOSITION
CR20130406A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE HUMAN ANTIBODIES AGAINST PCSK9
BR112014003052A2 (en) pharmaceutical compositions
DK2706982T4 (en) INTRANASAL PHARMACEUTICAL DOSAGE FORMS INCLUDING NALOXON
BR112014007261A2 (en) pharmaceutical order picker
CO6930367A2 (en) Pharmaceutical compositions
CO6940426A2 (en) Pharmaceutical formulations
DK2685898T3 (en) CALCULATION OF A MEDICATION DOSE
DK2819648T3 (en) PHARMACEUTICAL PREPARATION CONTAINING AN ANTIVIRAL EFFECTIVE DIHYDROQUINAZOLINE DERIVATIVE
DK2815752T3 (en) ORAL PHARMACEUTICAL COMPOSITION
DK2502622T3 (en) Pharmaceutical formulation comprising inositol
BR112014009319A2 (en) pharmaceutical compounds
ES2641042T8 (en) Procedure for the manufacture of a protein drug
CO7010828A2 (en) Pharmaceutical preparation comprising substituted ßcyclodextrin
DK2751239T3 (en) MULTIPLE-SCREEN SYSTEM FOR MANUFACTURING A DISINFECTANT
CO7091176A2 (en) Pharmaceutical diagnosis
BR112014004591A2 (en) light exposure analysis pharmaceutical product of a pharmaceutical product
DK2748584T3 (en) PARALLEL OPTICAL EXAMINATIONS OF A SAMPLE
CO6900137A2 (en) Chewable Ibuprofen Tablet
ES1077248Y (en) LIGHT PROJECTOR DEVICE
DK2908836T3 (en) Pharmaceutical formulation containing curcuma

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]